Adsense Skyscrapper

Ghanaian Scientist Glows At Global Prostate Cancer Confab With New Innovation


Affecting millions of men across the globe, Prostate Cancer is probably the most petrifying ailment a man could ever encounter in his life time.

To ensure that many do not go down the rabbit hole of despair, Ghanaian Prostate scientist and founder of the Dr. Nyarkotey College of Holistic Medicine, Dr Raphael Nyarkotey Obu, has come up with yet another health intervention that would help fight the disease.

Dr Nyarkotey after years of intensive and extensive research has formulated what he calls the Men’ Formula and presented it to the global prostate fraternity for checks and balances.

The Men’s Formula which is manufactured by the RNG Medical Research Lab in Ghana has been formulated with 14 different prostate Phyto ingredients.

According to the renowned prostate expert, this is the first Ghanaian product that contains such ingredients and has been formulated based on science and research.

Dr. Nyarkotey presented his findings at the Global Prostate Cancer Disparities Conference held at the University of Ilorin, Nigeria.

Dr Raphael Nyarkotey Obu

At the conference, Dr. Nyakotey made an outstanding presented on the development of evidence based natural product to slow localized prostate cancer aggressiveness & reducing risk in Ghanaian men.

This is the first time a natural product from Ghana has been presented at a scientific conference on prostate cancer.

The product has passed through all animal analysis and Dr. Nyarkotey has partnered several world centres to start clinical trials in humans.

Global Prostate Cancer Conference

The conference which began on November 7 through to November 10, 2018 was organised by the University of Florida, US.

For the first time, the conference was held Africa and focused on exploring the environmental, lifestyle, and genetic risk factors associated with prostate cancer in black men.

It further provided opportunities for mutual learning, knowledge transfer, and collaborations among prostate cancer scientists, clinicians, survivors, and advocates.

Grace Ablewor Sogbey

Leave A Reply

Your email address will not be published.